| β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer SP Tenbaum, P Ordóñez-Morán, I Puig, I Chicote, O Arqués, S Landolfi, ... Nature medicine 18 (6), 892-901, 2012 | 315 | 2012 |
| Global and regional gray matter reductions in ADHD: a voxel-based morphometric study S Carmona, O Vilarroya, A Bielsa, V Tremols, JC Soliva, M Rovira, ... Neuroscience Letters 389 (2), 88-93, 2005 | 306 | 2005 |
| sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ... EMBO molecular medicine 8 (5), 466-476, 2016 | 220 | 2016 |
| The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem E Alvarez, MD Martínez, I Roncero, JA Chowen, B García‐Cuartero, ... Journal of neurochemistry 92 (4), 798-806, 2005 | 209 | 2005 |
| Imaging Brain Inflammation with [11C]PK11195 by PET and Induction of the Peripheral-Type Benzodiazepine Receptor after Transient Focal Ischemia in Rats S Rojas, A Martín, MJ Arranz, D Pareto, J Purroy, E Verdaguer, J Llop, ... Journal of Cerebral Blood Flow & Metabolism 27 (12), 1975-1986, 2007 | 146 | 2007 |
| Influence of the normalization template on the outcome of statistical parametric mapping of PET scans JD Gispert, J Pascau, S Reig, R Martinez-Lazaro, V Molina, ... Neuroimage 19 (3), 601-612, 2003 | 146 | 2003 |
| Ventro-striatal reductions underpin symptoms of hyperactivity and impulsivity in attention-deficit/hyperactivity disorder S Carmona, E Proal, EA Hoekzema, JD Gispert, M Picado, I Moreno, ... Biological psychiatry 66 (10), 972-977, 2009 | 133 | 2009 |
| Biodistribution of Amino-Functionalized Diamond Nanoparticles. In Vivo Studies Based on 18F Radionuclide Emission. S Rojas, JD Gispert, R Martin, S Abad, C Mench n, D Pareto, VM V ctor, ... ACS nano, 2011 | 129 | 2011 |
| Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia V Molina, S Reig, J Sanz, T Palomo, C Benito, J Sánchez, F Sarramea, ... Schizophrenia Research 80 (1), 61-71, 2005 | 115 | 2005 |
| Synthesis and In Vivo Evaluation of the Biodistribution of a 18F-Labeled Conjugate Gold-Nanoparticle-Peptide with Potential Biomedical Application S Guerrero, JR Herance, S Rojas, JF Mena, JD Gispert, GA Acosta, ... Bioconjugate chemistry 23 (3), 399-408, 2012 | 99 | 2012 |
| Pediatric OCD structural brain deficits in conflict monitoring circuits: a voxel-based morphometry study S Carmona, N Bassas, M Rovira, JD Gispert, JC Soliva, M Prado, J Tomas, ... Neuroscience Letters 421 (3), 218-223, 2007 | 94 | 2007 |
| Method for bias field correction of brain T1‐weighted magnetic resonance images minimizing segmentation error JD Gispert, S Reig, J Pascau, JJ Vaquero, P García‐Barreno, M Desco Human brain mapping 22 (2), 133-144, 2004 | 84 | 2004 |
| Enhanced neural activity in frontal and cerebellar circuits after cognitive training in children with attention‐deficit/hyperactivity disorder E Hoekzema, S Carmona, V Tremols, JD Gispert, M Guitart, J Fauquet, ... Human Brain Mapping 31 (12), 1942-1950, 2010 | 82 | 2010 |
| Monitoring gene therapy by external imaging of mRNA: pilot study on murine erythropoietin J Segura, C Fillat, D Andreu, J Llop, O Millan, BG de la Torre, Z Nikolovski, ... Therapeutic drug monitoring 29 (5), 612, 2007 | 79 | 2007 |
| N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration V Molina, J Sánchez, S Reig, J Sanz, C Benito, C Santamarta, J Pascau, ... Schizophrenia research 73 (2-3), 209-219, 2005 | 72 | 2005 |
| Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement V Molina, JD Gispert, S Reig, J Sanz, J Pascau, A Santos, M Desco, ... Psychopharmacology 178 (1), 17-26, 2005 | 69 | 2005 |
| Cerebral metabolic patterns in chronic and recent-onset schizophrenia M Desco, JD Gispert, S Reig, J Sanz, J Pascau, F Sarramea, C Benito, ... Psychiatry Research: Neuroimaging 122 (2), 125-135, 2003 | 66 | 2003 |
| A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells I Puig, I Chicote, SP Tenbaum, O Arqués, JR Herance, JD Gispert, ... Clinical Cancer Research 19 (24), 6787-6801, 2013 | 63 | 2013 |
| Hypofrontality in men with first-episode psychosis V Molina, J Sanz, S Reig, R Martinez, F Sarramea, R Luque, C Benito, ... The British Journal of Psychiatry 186 (3), 203-208, 2005 | 62 | 2005 |
| Cerebral metabolism and risperidone treatment in schizophrenia V Molina, JD Gispert, S Reig, J Sanz, J Pascau, A Santos, T Palomo, ... Schizophrenia research 60 (1), 1-7, 2003 | 61 | 2003 |
Manuel DescoUniversidad Carlos III de Madrid. Instituto de Investigacion Sanitaria Gregorio MarañónDirección de correo verificada de hggm.es
